Hosted by ReachMD · EN · 440 episodes
Established thought leaders with verified media credentials.
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
ReachMD hosts CME/CE, a science show with 440 episodes published.
Faculty: Anjali Owens, MD This activity examines the evolving management of obstructive hypertrophic cardiomyopathy (oHCM), from persistent unmet needs to precision-based therapy with cardiac myosin inhibitors. Faculty r
Show notesFaculty: Brendon Neuen, MBBS, PhD Recent updates to the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) emphasized the expanded role of IV iron replacement therapy in p
Show notesFaculty: Deepak Sambhara, MD This rebroadcast of a live regional meeting series, part of The Focused Sight Initiative: Quality Improvement Interventions in Retinal Diseases, brings together retina specialists and eye car
Show notesFaculty: Richard Lafayette, MD, FACP Faculty: Ankana Daga, MD Complement-mediated kidney diseases such as C3 glomerulopathy (C3G) continue to present significant diagnostic and therapeutic challenges in nephrology for bo
Show notesFaculty: Ravindra Uppaluri, MD, PhD Faculty: Nancy Lee, MD, FASTRO This activity reviews data from the KEYNOTE-689 and NIVOPOSTOP trials evaluating perioperative immune checkpoint inhibition in resectable, locally advanc
Show notesFaculty: Mariana C. Castells, MD, PhD Faculty: Tsewang Tashi, MD This online educational activity explores the evolving role of KIT-targeted tyrosine kinase inhibitors (TKIs) in indolent systemic mastocytosis (ISM). Expe
Show notesFaculty: Antoine Lanot, MD, PhD Faculty: Gil Yosipovitch, MD Despite effective and recommended therapies, many healthcare providers still consider antihistamines as the first-choice treatment for CKD-associated pruritus.
Show notesFaculty: Michael Nassif, MD, MSc Faculty: Anjali Owens, MD This activity examines the evolving management of obstructive hypertrophic cardiomyopathy (oHCM), from persistent unmet needs to precision-based therapy with car
Show notesFaculty: Michael Nassif, MD, MSc Faculty: Anjali Owens, MD This activity examines the evolving management of obstructive hypertrophic cardiomyopathy (oHCM), from persistent unmet needs to precision-based therapy with car
Show notesFaculty: Maria Pabon, MD Faculty: Robert J. Mentz, MD, FHFSA, FACC In this brief podcast, Drs. Maria Pabon and Robert Mentz explore the evolving role of mineralocorticoid receptor antagonism in heart failure, with emphas
Show notesFaculty: Ahmad Masri, MD, MS Faculty: Anjali Owens, MD This activity examines the evolving management of obstructive hypertrophic cardiomyopathy (oHCM), from persistent unmet needs to precision-based therapy with cardiac
Show notesFaculty: Ahmad Masri, MD, MS Faculty: Anjali Owens, MD This activity examines the evolving management of obstructive hypertrophic cardiomyopathy (oHCM), from persistent unmet needs to precision-based therapy with cardiac
Show notesFaculty: Michael Nassif, MD, MSc This activity examines the evolving management of obstructive hypertrophic cardiomyopathy (oHCM), from persistent unmet needs to precision-based therapy with cardiac myosin inhibitors. Fa
Show notesFaculty: Ahmad Masri, MD, MS Faculty: Anjali Owens, MD This activity examines the evolving management of obstructive hypertrophic cardiomyopathy (oHCM), from persistent unmet needs to precision-based therapy with cardiac
Show notesFaculty: Christyn Edmundson, MD Faculty: Gil I. Wolfe MD, FAAN This program examines treat-to-target (T2T) principles in generalized myasthenia gravis (gMG), emphasizing measurable goals such as minimal manifestation sta
Show notesFaculty: Christyn Edmundson, MD Faculty: Gil I. Wolfe MD, FAAN This program examines treat-to-target (T2T) principles in generalized myasthenia gravis (gMG), emphasizing measurable goals such as minimal manifestation sta
Show notesFaculty: Christyn Edmundson, MD Faculty: Gil I. Wolfe MD, FAAN This program examines treat-to-target (T2T) principles in generalized myasthenia gravis (gMG), emphasizing measurable goals such as minimal manifestation sta
Show notesFaculty: Christyn Edmundson, MD Faculty: Gil I. Wolfe MD, FAAN This program examines treat-to-target (T2T) principles in generalized myasthenia gravis (gMG), emphasizing measurable goals such as minimal manifestation sta
Show notesFaculty: Christyn Edmundson, MD Faculty: Gil I. Wolfe MD, FAAN This program examines treat-to-target (T2T) principles in generalized myasthenia gravis (gMG), emphasizing measurable goals such as minimal manifestation sta
Show notesFaculty: Christyn Edmundson, MD Faculty: Gil I. Wolfe MD, FAAN This program examines treat-to-target (T2T) principles in generalized myasthenia gravis (gMG), emphasizing measurable goals such as minimal manifestation sta
Show notesSponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
CME/CE has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
CME/CE is hosted by ReachMD. The show is categorised under science (medicine) and has published 440 episodes.
CME/CE has published 440 episodes.
CME/CE regularly covers science, medicine, health. It sits in the science category, with a medicine focus.
CME/CE is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
CME/CE hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of CME/CE average 11 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates CME/CE's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 9 days ago.
